Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

by Mestre, Maria Teresa , Olona, Montserrat , Boqué, Carme , Ruiz‐Mateos, Ezequiel , Buzón, Maria José , García‐Pardo, Graciano , Benavent‐Bofill, Clara , Martí, Anna , López‐Cortés, Luis F. , Burgos, Joaquin , Peraire, Joaquim , Auguet, Teresa , Rull, Anna , Vidal, Francesc , Viladés, Consuelo , Reverté, Laia , Yeregui, Elena , Gutiérrez‐Valencia, Alicia , Gómez‐Bertomeu, Frederic

in Alpha-Globulins - metabolism / Biomarkers / Biomarkers - metabolism / Cholesterol Esters - metabolism / Coronaviruses / COVID-19 / COVID-19 - metabolism / COVID-19 - therapy / COVID-19 - virology / Glutamic Acid - metabolism / Humans / Letter to Editor / Metabolites / Severity of Illness Index / Treatment Outcome

2022

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

2022

Confirm

Do you wish to request the book?

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

2022

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?